contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls {
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


arjos-year-end-report-january-december-2023

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

pageUrl

alternatePageUrls

imgUrl

description

Arjo is a global company with operations in the healthcare industry. The company is today specialized in the development of medical devices. The product portfolio is broad and includes, for example, medical beds, floor and ceiling lifts, disinfection solutions, as well as hygiene products, and compression solutions. In addition, service and related services, as well as training, are offered. The largest operations are found in Europe and North America.

Arjo

"We are ending 2023 with healthy growth, significantly improved earnings and strong operating cash flow. During the year considerable focus was put on profitable growth in a market characterized...

<div class="abstract">"We are ending 2023 with healthy growth, significantly improved earnings and strong operating cash flow. During the year considerable focus was put on profitable growth in a market characterized by stabilization and recovery. We are now continuing our efforts to further strengthen our positions during 2024 and beyond," says Joacim Lindoff, President and CEO of Arjo.</div>October-December 2023 in brief<ul><li>Net sales increased to SEK 2,879 M (2,686).</li></ul>Net sales grew organically by 4.9%.<ul><li>Adjusted EBITDA increased 27.6% to SEK 614 M (481).</li><li>Adjusted operating profit increased 52.4% to SEK 342 M (224).</li><li>Profit after financial items increased to SEK 242 M (133).</li><li>Earnings per share rose to SEK 0.67 (0.37).</li><li>Cash flow from operations rose to SEK 734 M (425), corresponding to a cash conversion of 124.6% (99.4).</li><li>A dividend per share of SEK 0.90 (0.85) is proposed, corresponding to approximately SEK 245 M.</li></ul>Telephone conferenceFund managers, analysts and media are invited to participate in a conference call and presentation of the report on January 30 at 08.00 CET via the following link:&nbsp;<a href="https://ir.financialhearings.com/arjo-q4-report-2023">https://ir.financialhearings.com/arjo-q4-report-2023</a>Those who wish to ask questions verbally during the teleconference will need to register via the link below. A phone number and a conference ID will be provided after registration in order to access the conference. Link to registration: <a href="https://conference.financialhearings.com/teleconference/?id=5001443">https://conference.financialhearings.com/teleconference/?id=5001443</a>Alternatively, use the following link to download the presentation: <a href="https://www.arjo.com/int/about-us/investors/reports--presentations/2024/">https://www.arjo.com/int/about-us/investors/reports--presentations/2024/</a>&nbsp;A recorded version of the conference is accessible for three years via the following link: <a href="https://ir.financialhearings.com/arjo-q4-report-2023">https://ir.financialhearings.com/arjo-q4-report-2023</a>For more information, please contact:Maria Nilsson, EVP Communications &amp; Public RelationsTel: +46 734 244 515Email: maria.nilsson@arjo.com&nbsp;Sara Ehinger, VP Investor Relations &amp; Corporate CommunicationsTel: +46 723 597 794Email: sara.ehinger@arjo.comThis information is information that Arjo AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 07:00 CET on January 30, 2024.About ArjoAt Arjo, we believe that empowering movement within healthcare environments is essential to quality care. Our products and solutions are designed to promote a safe and dignified experience through patient handling, medical beds, personal hygiene, disinfection, diagnostics, and the prevention of pressure injuries and venous thromboembolism. With more than 6,500 people worldwide and over 65 years caring for patients and healthcare professionals, we are committed to driving healthier outcomes for people facing mobility challenges. www.arjo.com

Pysy ajantasalla Inderesin uutiskirjeillä